Saipu Biotechnology (Changchun) Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Saipu Biotechnology (Changchun) Co., Ltd. - overview
Established
2019
Location
Changchun, Jilin, China
Primary Industry
Biotechnology
About
Founded in 2019 and based in Changchun, China, Saipu Biotechnology Changchun Co. , Ltd. develops stem cell products and recombinant protein therapeutics for the biotechnology and pharmaceutical industries. The company focuses on research activities, production processes, and clinical translation.
In December 2025, the firm closed a round of venture funding. The company works with pharmaceutical companies, research institutions, and medical organizations to provide stem cell products, recombinant protein drug candidates and biomedical research services. The company generates revenue through the research development projects of stem cell products and recombinant protein pharmaceutical products.
Current Investors
Huize Investment, Jinjiuruihe, Changchun Saizhi Kewei Management Consulting
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.